Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nicholas J. Vogelzang
US Oncology Research/Comprehensive Cancer Centers of Nevada
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
177 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitatsklinikum Fur Urologie Und Andrologie
Salzburg, Austria
- Akh Universitatskrankenhaus Wien
Vienna, Austria
- Krankenhaus Barmherzige Brueder
Vienna, Austria
- N.N. Alexandrov National Research Center
Lesnoy, Belarus
- Minsk City Oncological Hospital
Minsk, Belarus
- Clinique D'Oncologie Medicale Institut Jules Bordet
Brussels, Belgium
- Cliniques Universitaires Saint Luc- Urologie
Brussels, Belgium
- Erasme Hospital- Urologie
Brussels, Belgium
- Urologie Uz Gent
Ghent, Belgium
- Urology Department St. Elizabeth Ziekenhuis
Turnhout, Belgium
- Specialized Hospital for Active Treatment in Oncology
Haskovo, Bulgaria
- Central Oncology Hospital
Plovdiv, Bulgaria
- Complex Oncology Center
Plovdiv, Bulgaria
- Multifunctional Hospital for Active Treatment Serdika
Sofia, Bulgaria
- Specialized Hospital for Active Treatment of Oncology Diseases
Sofia, Bulgaria
- General Hospital Varazdin
Varaždin, Croatia
- Clinical Hospital Center Zagreb
Zagreb, Croatia
- University Hospital Center Sisters of Charity
Zagreb, Croatia
- Onkologicke Centrum, Nemocnice Chomutov
Chomutov, Czechia
- Klinika Onkologie A Radioterapie, Fakultni Nemocnice
Hradec Králové, Czechia
- Nemocnice Jihlava, Urologicke Oddeleni
Jihlava, Czechia
- Urologicke Oddeleni, Krajska Nemocnice
Liberec, Czechia
- Onkologicka Klinika, Fakultni Nemocnice
Olomouc, Czechia
- Klinika Onkologicka, Fakultni Nemocnice
Ostrava-Poruba, Czechia
- Fakultni Nemocnice Kralovske Vinohrady
Prague, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Thomayerova Nemocnice
Prague, Czechia
- Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
- Krajska Zdravotni, Urologicke Oddeleni
Ústí nad Labem, Czechia
- Rigshospitalet
Copenhagen, Denmark
- Hegp Medical Oncology
Paris, France
- Hopital St. Joseph
Paris, France
- Hospital Cochin, Service de Urologie
Paris, France
- St-Louis Idf Medical Oncology
Paris, France
- Hia Begin
Saint-Mandé, France
- Hospital Civil de Strasbourg
Strasbourg, France
- Charite Universitatsklinikum Berlin
Berlin, Germany
- Stadtisches Klinikum Braunschweig
Braunschweig, Germany
- Klinik Und Poliklinik Urologie
Cologne, Germany
- Universtatsklinikum Carl Gustav Carus
Dresden, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 May 2014
- Primary completion
- 28 Jan 2020
- Completion
- 28 Jan 2020
- Last update posted
- 6 Apr 2021
- Registered enrollment
- 1,182
- Registry id
- NCT02111577
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.